About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 34 record(s)
Req # A-2021-03662
Copies of all documentation indicating how excessive revenue payments claimed from pharmaceutical companies were handled and how such payments are processed by the PMPRB.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2020-18437
Copies of all work plans, regulatory processes, consultation processes and departmental reports from June 1, 2020 to November 26, 2020. Include, but do not limit the scope of the request to, documents that detail the internal reporting and…Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2020-01436
Copies of reports, discussions, briefings, memos and decisions related to the introductory price review for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020
Req # A-2020-04137
Copies of the PMPRB documentation related to the scientific review and pricing review of erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020